EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32005D0934

2005/934/EC: Commission Decision of 21 December 2005 amending Decisions 2004/696/EC and 2004/863/EC as regards the reallocation of the Community's financial contribution to the TSE eradication and monitoring programmes of the Member States for 2005 (notified under document number C(2005) 5564)

OJ L 340, 23.12.2005, p. 73–77 (ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
OJ L 349M, 12.12.2006, p. 714–718 (MT)

Legal status of the document In force

ELI: http://data.europa.eu/eli/dec/2005/934/oj

23.12.2005   

EN

Official Journal of the European Union

L 340/73


COMMISSION DECISION

of 21 December 2005

amending Decisions 2004/696/EC and 2004/863/EC as regards the reallocation of the Community's financial contribution to the TSE eradication and monitoring programmes of the Member States for 2005

(notified under document number C(2005) 5564)

(2005/934/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), and in particular Article 24(5) and (6) thereof,

Whereas:

(1)

Commission Decision 2004/696/EC of 14 October 2004 on the list of programmes for the eradication and the monitoring of certain TSEs qualifying for a financial contribution from the Community in 2005 (2), lists the programmes submitted to the Commission by the Member States for the eradication and monitoring of transmissible spongiform encephalopathies (TSE) qualifying for a Community financial contribution in 2005. That Decision also sets out the proposed rate and maximum amount of the contribution for each programme.

(2)

Commission Decision 2004/863/EC of 30 November 2004 approving the TSE eradication and monitoring programmes of certain Member States for 2005 and fixing the level of the Community's financial contribution (3), approves the programmes which are listed in Decision 2004/696/EC and lays down the maximum amounts of the Community's financial contribution.

(3)

Decision 2004/863/EC also provides for reports on the progress of the TSE monitoring programmes and the costs paid, to be forwarded by the Member States to the Commission every month. An analysis of those reports indicates that certain Member States will not utilise their full allocation for 2005, while others will spend in excess of the allocated amount.

(4)

The Community's financial contribution to certain of those programmes therefore needs to be adjusted. It is appropriate to reallocate funding from programmes of Member States which are not using their full allocation to those that are exceeding it. The reallocation should be based on the most recent information on the expenditure actually incurred by the concerned Member States.

(5)

Decisions 2004/696/EC and 2004/863/EC should therefore be amended accordingly.

(6)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

The Annexes to Decision 2004/696/EC are amended in accordance with the Annex to this Decision.

Article 2

Decision 2004/863/EC is amended as follows:

1.

In Article 7(2), ‘EUR 8 846 000’ is replaced by ‘EUR 8 536 000’;

2.

In Article 10(2), ‘EUR 8 677 000’ is replaced by ‘EUR 8 397 000’;

3.

In Article 11(2), ‘EUR 353 000’ is replaced by ‘EUR 503 000’;

4.

In Article 16(2), ‘EUR 4 510 000’ is replaced by ‘EUR 4 840 000’;

5.

In Article 18(2), ‘EUR 1 480 000’ is replaced by ‘EUR 1 540 000’;

6.

In Article 21(2), ‘EUR 313 000’ is replaced by ‘EUR 363 000’;

7.

In Article 24(2), ‘EUR 250 000’ is replaced by ‘EUR 100 000’;

8.

In Article 25(2), ‘EUR 2 500 000’ is replaced by ‘EUR 3 350 000’;

9.

In Article 26(2), ‘EUR 200 000’ is replaced by ‘EUR 80 000’;

10.

In Article 28(2), ‘EUR 25 000’ is replaced by ‘EUR 20 000’;

11.

In Article 29(2), ‘EUR 150 000’ is replaced by ‘EUR 20 000’;

12.

In Article 31(2), ‘EUR 500 000’ is replaced by ‘EUR 310 000’;

13.

In Article 35(2), ‘EUR 150 000’ is replaced by ‘EUR 30 000’;

14.

In Article 36(2), ‘EUR 450 000’ is replaced by ‘EUR 460 000’;

15.

In Article 37(2), ‘EUR 10 000’ is replaced by ‘EUR 25 000’;

16.

In Article 38(2), ‘EUR 975 000’ is replaced by ‘EUR 845 000’;

17.

In Article 39(2), ‘EUR 25 000’ is replaced by ‘EUR 10 000’;

18.

In Article 41(2), ‘EUR 25 000’ is replaced by ‘EUR 10 000’;

19.

In Article 45(2), ‘EUR 20 000’ is replaced by ‘EUR 120 000’;

20.

In Article 49(2), ‘EUR 1 555 000’ is replaced by ‘EUR 865 000’;

21.

In Article 50(2), ‘EUR 9 525 000’ is replaced by ‘EUR 9 035 000’;

22.

In Article 51(2), ‘EUR 1 300 000’ is replaced by ‘EUR 2 400 000’;

23.

In Article 54(2), ‘EUR 5 565 000’ is replaced by ‘EUR 5 075 000’;

24.

In Article 58(2), ‘EUR 5 000’ is replaced by ‘EUR 55 000’;

25.

In Article 59(2), ‘EUR 575 000’ is replaced by ‘EUR 755 000’;

26.

In Article 61(2), ‘EUR 695 000’ is replaced by ‘EUR 915 000’;

27.

In Article 64(2), ‘EUR 5 000’ is replaced by ‘EUR 25 000’.

Article 3

This Decision is addressed to the Member States.

Done at Brussels, 21 December 2005

For the Commission

Markos KYPRIANOU

Member of the Commission


(1)  OJ L 224, 18.8.1990, p. 19. Decision as last amended by Directive 2003/99/EC of the European Parliament and of the Council (OJ L 325, 12.12.2003, p. 31).

(2)  OJ L 316, 15.10.2004, p. 91. Decision as amended by Decision 2005/413/EC (OJ L 141, 4.6.2005, p. 24).

(3)  OJ L 370, 17.12.2004, p. 82. Decision as amended by Decision 2005/413/EC.


ANNEX

Annexes I, II and III to Decision 2004/696/EC are replaced by the following:

ANNEX I

List of programmes for the monitoring of TSEs

Rate and maximum amount of the Community financial contribution

(in EUR)

Disease

Member State

Rate tests performed (1)

Maximum amount

TSEs

Austria

100 %

2 076 000

Belgium

100 %

3 586 000

Cyprus

100 %

503 000

Czech Republic

100 %

1 736 000

Denmark

100 %

2 426 000

Estonia

100 %

294 000

Finland

100 %

1 170 000

France

100 %

29 755 000

Germany

100 %

15 170 000

Greece

100 %

1 487 000

Hungary

100 %

1 184 000

Ireland

100 %

6 172 000

Italy

100 %

8 397 000

Lithuania

100 %

836 000

Luxembourg

100 %

155 000

Malta

100 %

36 000

Netherlands

100 %

4 840 000

Portugal

100 %

1 540 000

Slovenia

100 %

444 000

Spain

100 %

8 536 000

Sweden

100 %

363 000

United Kingdom

100 %

5 690 000

Total

96 396 000

ANNEX II

List of programmes for the eradication of BSE

Maximum amount of the Community financial contribution

(in EUR)

Disease

Member State

Rate

Maximum amount

BSE

Austria

50 % culling

25 000

Belgium

50 % culling

100 000

Cyprus

50 % culling

25 000

Czech Republic

50 % culling

3 350 000

Denmark

50 % culling

80 000

Estonia

50 % culling

20 000

Finland

50 % culling

10 000

France

50 % culling

310 000

Germany

50 % culling

875 000

Greece

50 % culling

20 000

Ireland

50 % culling

4 000 000

Italy

50 % culling

205 000

Luxembourg

50 % culling

30 000

Netherlands

50 % culling

460 000

Portugal

50 % culling

845 000

Slovak Republic

50 % culling

25 000

Slovenia

50 % culling

10 000

Spain

50 % culling

1 320 000

United Kingdom

50 % culling

4 235 000

Total

15 945 000

ANNEX III

List of programmes for the eradication of scrapie

Maximum amount of the Community financial contribution

(in EUR)

Disease

Member State

Rate

Maximum amount

Scrapie

Austria

50 % culling; 100 % genotyping

10 000

Belgium

50 % culling; 100 % genotyping

105 000

Cyprus

50 % culling; 100 % genotyping

5 075 000

Czech Republic

50 % culling; 100 % genotyping

120 000

Denmark

50 % culling; 100 % genotyping

5 000

Estonia

50 % culling; 100% genotyping

10 000

Finland

50 % culling; 100% genotyping

25 000

France

50 % culling; 100 % genotyping

2 400 000

Germany

50 % culling; 100 % genotyping

2 275 000

Greece

50 % culling; 100 % genotyping

865 000

Hungary

50 % culling; 100 % genotyping

55 000

Ireland

50 % culling; 100 % genotyping

800 000

Italy

50 % culling; 100 % genotyping

2 485 000

Latvia

50 % culling; 100 % genotyping

5 000

Lithuania

50 % culling; 100 % genotyping

5 000

Luxembourg

50 % culling; 100 % genotyping

35 000

Netherlands

50 % culling; 100 % genotyping

755 000

Portugal

50 % culling; 100 % genotyping

915 000

Slovak Republic

50 % culling; 100 % genotyping

340 000

Slovenia

50 % culling; 100 % genotyping

65 000

Spain

50 % culling; 100 % genotyping

9 035 000

Sweden

50 % culling; 100 % genotyping

10 000

United Kingdom

50 % culling; 100 % genotyping

7 380 000

Total

32 775 000


(1)  Rapid tests and primary molecular tests.


Top